JPMorgan Upgrades Integra LifeSciences (IART) to Overweight
Get Alerts IART Hot Sheet
Price: $35.45 +1.78%
Rating Summary:
10 Buy, 13 Hold, 3 Sell
Rating Trend: Up
Today's Overall Ratings:
Up: 13 | Down: 11 | New: 11
Rating Summary:
10 Buy, 13 Hold, 3 Sell
Rating Trend: Up
Today's Overall Ratings:
Up: 13 | Down: 11 | New: 11
Join SI Premium – FREE
JPMorgan upgraded Integra LifeSciences (NASDAQ: IART) from Neutral to Overweight with a price target of $80.00.
For an analyst ratings summary and ratings history on Integra LifeSciences click here. For more ratings news on Integra LifeSciences click here.
Shares of Integra LifeSciences closed at $64.00 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- HSBC Upgrades Xinte Energy Co Ltd (1799:HK) to Hold, 'cost cutting efforts likely to keep away from loss making'
- Exane BNP Paribas Upgrades Omnicom Group (OMC) to Outperform
- JPMorgan Upgrades Nippon Electric Glass Co Ltd (5214:JP) to Overweight
Create E-mail Alert Related Categories
UpgradesRelated Entities
JPMorganSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!